1177:HKG
Sino Biopharmaceutical Ltd
HK$4.66
arrow_downward
-0.85%(-0.040) 1D
Jun 5, 4:09:10 PM GMT+8 · HKD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 1177...
Open
HK$4.76
High
HK$4.82
Low
HK$4.60
Mkt. cap
87.73B
Avg. vol.
77.85M
Volume
82.51M
Dividend
2.15%
Quarterly dividend
HK$0.03
Ex-dividend date
Aug 29, 2025
P/E ratio
31.01
52-wk high
HK$9.12
52-wk low
HK$4.42
EPS
HK$0.15
Shares outstanding
12.64B
No. of employees
21K
Open
HK$4.76
High
HK$4.82
Low
HK$4.60
Mkt. cap
87.73B
Avg. vol.
77.85M
Volume
82.51M
Dividend
2.15%
Quarterly dividend
HK$0.03
Ex-dividend date
Aug 29, 2025
P/E ratio
31.01
52-wk high
HK$9.12
52-wk low
HK$4.42
EPS
HK$0.15
Shares outstanding
12.64B
No. of employees
21K
Analyst outlook
Analyst Ratings
Based on 11 analysts giving stock ratings to 1177 in the past 3 months
Strong Buy
Buy
11
Hold
0
Sell
0
12 month forecast
Based on 11 Wall Street analysts offering 12 month price targets for 1177 in the last 3 months.
Highest
Current HK$4.66
HK$11.00 (+136.05%)
Average
HK$8.46 (+81.50%)
Lowest
HK$6.50 (+39.48%)
News stories
From sources across the web
CNBC
·
29 minutes ago
Stock futures fall after Nasdaq rout as investors look ahead to SpaceX IPO: Live updates
Yahoo Finance
·
3 hours ago
1 Costly Mistake Too Many Investors Make With the Vanguard S&P 500 ETF (VOO)
MarketWatch
·
2 days ago
S&P 500 sees $1.8 trillion wipeout, Nasdaq tallies biggest point drop on record: What investors need to know about Friday’s selloff
Bloomberg.com
·
3 days ago
SpaceX, Other Mega IPOs Denied Fast Index Entry by S&P
Profile
Sino Biopharmaceutical Limited, shortly Sino Biopharm, is a pharmaceutical conglomerate in China. The Company was listed on the Hong Kong Stock Exchange in 2000 and included in 2013 as a constituent stock of MSCI Global Standard Indices – MSCI China Index, Hang Seng Index in 2018, Hang Seng China Enterprises Index in 2019, and Hang Seng Connect Biotech 50 Index and Hang Seng China 25 Index in 2020.
The Group’s principal subsidiaries include: Chia Tai Tianqing Pharmaceutical Group Co. Ltd., Beijing Tide Pharmaceutical Co. Ltd., Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd., Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd., Jiangsu Chia Tai Qingjiang Pharmaceutical Co., Ltd. and invoX Pharma Limited. Its products including biopharmaceutical and chemical medicines are used in a host of therapeutic areas, such as tumors, liver diseases, respiratory system diseases and surgery/analgesia. Wikipedia
About Sino Biopharmaceutical Ltd
AI content may include mistakes. Learn more